R ecent studies of cells found In human atherosclerotic plaques have identified smooth muscle cells (SMC), some of which exhibit class II major histocompatibility (MHC) antigens. 1 ' 4 Most nucleated cells bear class I MHC determinants, but the finding of class II antigens on these cells was unexpected. MHC determinants are highly polymorphic cell surface glycoproteins that play a key role in recognition of foreign tissues and in antigen presentation to immunocompetent cells. 56 The traditional view considered only cells derived from bone marrow (including lymphocytes, mononuclear phagocytes, and Langerhans' and dendritic cells) to be capable to expressing class II MHC determinants, hence their common designation as human leukocyte antigens (HLA). It is now known that a variety of nonleukocytic cell types, although they ordinarily lack class II antigens, can synthesize these molecules under some conditions. For example, human vascular endothelial cells and fibroblasts and thyroid epithelial and neural cells can express such determinants after exposure to the cytokine immune or gamma interferon (IFN-y). 7 -12 In addition to SMC, human atheromata contain a considerable number of T-lymphocytes and macrophages. 2 -413 When activated, both of these cell types can elaborate a variety of cytokines including interleukins, tumor necrosis factors, or IFN-y. 14 Morphologic studies have established that the human atherosclerotic plaque contains HLA DR + SMC adjacent to such cytokine-producing cells. To learn more about the mechanisms that may mediate this unusual behavior of SMC in atheromata, we have examined the control of MHC gene expression by products of activated leukocytes as well as by defined recombinant cytokines in characterized cultures of human vascular SMC. Inducible expression of class II histocompatibility antigens by these vessel wall cells may be of significance in the pathogenesis of arteriosclerosis, in various vasculitides, and in allograft rejection.
Methods Cytoklnes
Recombinant human IFN-y was provided by Genentech, Incorporated (South San Francisco, CA), recombinant human leukocyte IFN-a A was supplied by Peter Sorter of Hoffman-LaRoche (Nutley, NJ), and natural human IFN-/J was purchased from Lee Biomolecular Research, Incorporated (San Diego, CA). Recombinant human interleukin-1a (IL-1a) was supplied by Peter Lomedico of Hoffman-LaRoche and recombinant interieukin-10 (IL-10) by Charles A. Dinarello of Tufts University (Boston, MA). Recombinant human interieukin-6 (IL-6), also known as ft inteferon, hepatic stimulating factor, or B cell stimulatory factor-2, was obtained from Genzyme, Incorporated (Boston, MA). Recombinant human tumor necrosis factor a (TNFa) was provided by Michael Palladino of Genentech, Incorporated.
Antibodies
Human class I histocompatibility antigens were detected using monoclonal antibody W6/32 (IgG 2a). 15 A hybridoma cell line expressing this antibody was supplied by Mark I. Green of the University of Pennsylvania (Philadelphia, PA). The IgG was isolated from hybridoma culture supematants by protein-A affinity chromatography. Class II histocompatlbillty antigens were detected using monoclonal antibody I-2 (IgG 2a), 16 supplied as mouse asdtes fluid by Lee Nadler and Stuart F. Schlossman of the Dana-Farber Cancer Institute (Boston, MA). A mouse IgG 2a K myeloma protein (UPC 10, Sigma Chemical Company, St. Louis, MO) was used as a type-and classmatched irrelevant antibody for control purposes. Jan Vilcek of New York University (New York, NY) provided bovine antihuman IFN-0 antiserum. Rabbit antinatural human IFN-y was purchased from Interferon Sciences, (New Brunswick, NJ).
Nucleic Add Probes
Class I HLA mRNA was detected using a 1.8-kilobase (kb) probe derived by Bgl II cleavage of a genomic clone of HLA B7 cDNA. 17 Messenger RNA for class II antigens was detected with a 550 bp Pst I fragment of DB10 probe for HLA DRa. 18 Beta-tubulin transcripts were detected with a 1.05-kb Bam HI to Pst I fragment of R0T.3, a gift of Stephen R. Farmer of Boston University, Boston, Massachusetts.
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Cell Cultures
Human vascular SMC were prepared from explants of unused portions of saphenous veins obtained at the time of coronary artery bypass surgery. 20 This use of normally discarded human tissues was approved by the Human Investigation Review Committee of New England Medical Center (Boston, MA). Aortic SMC were isolated enzymatically from the inner third of the tunica media of tissue obtained from organ donors, with the cooperation of the New England Organ Bank. The adventitia and abluminal two thirds of the tunica media were removed before dissociation of the tissue with collagenase. These cells were prepared, characterized, and cultured in Dulbecco's modified Eagle's (DME) medium containing fetal bovine serum (10%) with HEPES (25 mM). All components of tissue culture media were tested for endotoxin contamination using the chromogenic Limulus amebocyte lysate assay. Only media that contained a final concentration of endotoxin less than 40 pg/ml were used for these studies to avoid stimulation of endogenous cytokine production by the endotoxin-sensitjve SMC. These cells exhibited the typical morphologic characteristics of vascular smooth muscle in vitro, including a pattern of growth in hills and valleys. 20 Even after several passages in culture, many of these cells stained with HHF-35, a monoclonal antibody that selectively recognizes muscle-specific forms of actin and that does not react with endothelial cells or fibroblasts. 21 Human peripheral blood mononuclear cells (PBMNC) for mixed leukocyte reactions were prepared from venous blood obtained with informed consent from three healthy unrelated male adult donors. The blood was anticoagulated with heparin (100 U/ml), and PBMNC were isolated by centrifugation over Ficoll-Hypaque (400 g, 30 minutes, 20°C). The interface cells were washed with phosphatebuffered saline (PBS) and resuspended at 4.5x10 s cells/ml in DME supplemented with fetal calf serum (FCS) (10%). The cells from the three donors were mixed and incubated at 37°C for 4 days. 22 At the end of this period, the cells were sedimented by centrifugation, and the supematants were equilibrated with DME by repeated centrifugation by using a Centricon-10 device (Amicon, Bedford, MA). They were stored at -70°C.
RNA Extraction and Nucleic Add Hybridization
RNA was isolated from cultured SMC by phenol extraction after lysis in guanidinium isothiocyanate. 23 After electrophoresis on agarose gels (1.2%) that contained formaldehyde (2.2 M), the RNA was transferred to nylon membranes (Hybond-N, Amersham Company, Arlington Heights, IL). DNA probes were labeled by nick translation or by random hexanucleotide priming by using ^P-labeled nucleotide triphosphates. Prehybridization, hybridization, and autoradiograpny were done with standard techniques.
Measurement of Cell Surface Antigen Level by Enzyme-linked Immunosorbent Assay
SMC were cultured in 96-well plates for study by cell-based enzyme-linked immunosorbent assay (EUSA). 24 After treatment with the test stimulus, the cell layers were washed with PBS containing bovine serum albumin (BSA, 10 mg/ml) to block nonspecific binding sites. The wells were incubated with various dilutions of the test antibody or buffer alone for 2 hours at 4°C. The cell layers were then washed three times with PBS-BSA, then incubated for 1 hour with horse antimouse IgG antibody conjugated with biotin (Vector Laboratories, Buriingame, CA) diluted 1:1000. After an additional wash in PBS-BSA, the cell layers were incubated for 30 minutes with streptavidinalkaline phosphatase diluted 1:1000 (Zymed Laboratories, South San Francisco, CA). After this incubation, the cell layers were washed three more times with PBS-BSA and finally, with PBS alone. The cell-associated enzyme activity was then measured by incubation for 15 to 30 minutes with paranitrophenyl phosphate (1 mg/ml) in diethanolamine (0.1 M, pH 10.3) that contained levami-sole (1 mM, Sigma Chemical Company) to block endogenous phosphatase activity. 26 The reaction was stopped by addition of two volumes of sodium hydroxide (2 M), and the absorbance at 410 nm was read in an automated microplate photometer. Control incubations performed with equivalent dilutions of the irrelevant type-and classmatched antibody (UPC-10) run with most experiments yielded negligible absorbance.
Immunohlstochemlcal Evaluation of Major Hlstocompatlblllty Antigen Expression
SMC were cultured in Labtek 4-well chambers (Miles Laboratories, Naperville, IL). After treatment with the test stimulus, the cell layers were fixed with acetone at 4°C for 20 seconds and were evaluated by immunohistochemical studies with selective antibodies 1516 by using standard avidin-biotin immunoperoxidase techniques. 20 Cell layers were washed with PBS that contained horse serum (1%) for 10 minutes. Then, monoclonal antibody obtained as mouse ascttes fluid or IgG fraction was diluted 1:100 in PBS and incubated with the cell layers for 1 hour at ambient temperature. After washing with PBS, bkrtinylated horse antimouse IgG was applied for 40 minutes. The slides were again washed and incubated for 30 minutes with Vectastain ABC reagent, a mixture of avidin and biotinylated horseradish peroxidase (Vector Laboratories, Buriingame, CA). The slides were washed again and developed in peroxidase substrate solution [50 ml acetate buffer (0.1 M, pH 5.0) that contained 25 fi\ of a 30% hydrogen peroxide solution and aminoethylcarbazote (10 mg dissolved in 2.5 ml A/,A/-dimethytformamide)]. The controls in all immunohistochemical experiments included the omission of primary antibody and parallel reactions with panels of cells of known positive or negative reactivity.
Results
Secretory Products of Activated Human Leukocytes Induce Surface Expression of Major Hlstocompatlblllty Antigens on Smooth Muscle Cells
Human venous and arterial SMC expressed little or no class II MHC antigens under basal conditions in culture ( Figure 1 ) in accord with the in situ observations of Jonasson et al. 1 We tested whether products of activated leukocytes could induce class II MHC expression by SMC and might thus account for the finding of HLA DR + SMC in the vicinity of T-lymphocytes in the complicated atheromatous plaque. We exposed SMC for 72 hours to the conditioned medium derived from a three-way human mixed leukocyte reaction (MLR). 22 Such MLR supernatants contain a mixture of various cytokines secreted by the activated peripheral blood lymphocytes and mononuclear phagocytes. The MLR supernatant induced class II MHC antigen expression on the surfaces of cultured human aortic and venous SMC determined by ELISA (Figure 1 ). To determine which of the several bioactive cytokines found in MLR supematants might be involved in this regulation, we performed experiments with wellcharacterized candidates. These studies examined both surface expression of MHC antigens and levels of specific intracellular mRNAs to obtain evidence regarding the mechanism of modulation of immunoreactive MHC on the cell membrane.
Class I HLA Expression
Under basal conditions, cultured human vascular SMC contained mRNA that hybridized with a cDNA probe for HLA-B7 that recognizes a conserved region of class I MHC genes (Figure 2A ). In addition, the surfaces of these cells bound monoclonal antibody W6/32 that is specific for class I determinants ( Figure 3 ). Immunohistochemical examination of cultured SMC also revealed basal expression of class I MHC antigens (data not shown). After exposure for 72 hours to recombinant human IFN-a or -y, or natural human IFN-0, the mRNA level for class I MHC increased several fold (Figure 2A ). Antihuman-/3-interferon antjserum (5 /il/ml), but not nonimmune serum, abrogated the effect of IFN-/3 on class I MHC mRNA accumulation ( Figure 2A , 3rd through 6th lanes). Compared on the basis of antiviral potency, IFN-y appeared to augment class I MHC mRNA levels to a greater extent than the other IFNs tested (Figure 2A ). Although each of the recombinant human IFN species tested significantly increased the surface expression of class I antigen determined quantitatively by EUSA (Figure 3) , the magnitude of this increase was substantially less than the increase in the corresponding steady-state mRNA level. Inspection of SMC layers exposed to IFN-y and stained immunohistochemically for class I antigens showed no striking difference (data not shown), consistent with the modest changes in surface expression of these determinants documented by quantitative ELISA.
Exposure of SMC to IFN-a or IFN-y caused accumulation of class I HLA mRNA within 24 hours and produced maximal increases after 48 hours (Figure 4, middle row) .
Each of the IFN species tested increased the surface expression of class I antigens maximally after 24 to 48 hours (data not shown), lnterieukin-6 (IL-6), (also known as /Mnterferon, B cell stimulatory factor 2, or hepatic stimulatory factor) 27 had no significant effect on the surface expression of class I antigens on SMC (Figure 3 ).
Class II Human Leukocyte Antigen Expression
Although all cultures of SMC tested express class I MHC genes under basal conditions, we found little or no class II MHC mRNA in unstimulated SMC examined by using an HLA-DR probe that encodes well-conserved o chain sequences ( Figure 2B ). The surfaces of untreated SMC contained only low levels of immunoreactive class II MHC antigen measured by ELISA with monoclonal antibody 12 (Figures 1, 7, 8, and 9 ). Only occasional discrete cells in cultured monolayers of human SMC reacted with anticlass II antibody as detected by immunohistochemical staining (Figure 5A , arrowheads).
One product of activated leukocytes likely to mediate the induction of class II molecules on SMC by MLR supernatants is IFN-y. We tested the effect of purified human IFN-y made by recombinant DNA technology on this function of SMC. Incubation with this IFN-y caused marked accumulation of class II MHC mRNA by SMC ( Figures 2B and 4) . Immune IFN induced accumulation of this mRNA after 24 hours of exposure and produced maximal levels after 48 hours of treatment (Figure 4 , right hand panel). These increases in class II mRNA corresponded to induced surface expression of antigens reactive with anti-HLA-DR antibody (Figures 6, 7, 8, and 9) . Recombinant IFN-y (1000 U/ml for 72 hours) induced expression of class II MHC antigens on the surface of aortic, as well as venous, SMC determined by ELISA, an effect inhibited by anti-IFN-y antibody ( Figure 6 ). Immunohistochemical study demonstrated homogeneous indue- The concentration of Interferons a, /3, and y was 1000 U/ml. IL-6 (IFN-ft,) was included at 100 ng/ml. The expression of class I MHC antigen on the surface of the cultured cells was measured by enzyme-linked immunosorbent assay. Values obtained in parallel incubations with a type-and class-matched irrelevant antibody (UPC-10) were all less than 0.011 absorbance units and were subtracted from the data shown. Data plotted are the means±SD of three observations. Compared to incubation without cytokine by Student's f test, the increases produced by interferons a, /3, and y were significant (p=s0.004), but IL-6 produced no significant effect (p>0.08).
tjon of class II MHC antigen on human SMC exposed to IFN-y ( Figure 5 ).
These effects of IFN-y appeared selective, since the type I IFNs tested (recombinant human IFN-a or -p) did not induce accumulation of class II mRNA ( Figure 2B ). In addition, neither IL-1 a or p nor TNF a, recombinant human IFN-a, natural human IFN-0, nor bacterial lipopolysaccharide (LPS) increased surface expression of class II antigens (Figures 6 and 7) . The appearance of surface class II MHC antigen began during the second day of exposure to IFN-y and increased approximately linearly over the first 4 days of exposure (Figure 8 ). The SMC appeared to be quite sensitive to the effect of IFN-y, as only 10 U/ml induced approximately 50% of maximal surface expression of class II MHC antigen (Figure 9 ). The surface expression of class II molecules correlated quite closely with the corresponding mRNA levels. In the case of class I determinants, IFNs consistently affected steady-state mRNA levels to a greater extent than surface expression (compare Figure 3 However, the presence of numerous T-lymphocytes and class II MHC-bearing SMC in the advanced human atheroma was unexpected. Up to 20% of the cells in the "shoulder" portion of human carotid endarterectomy specimens are T-lymphocytes. 2 Uncomplicated "fatty streaks" in the aortas of young trauma victims also contain T-cells. 13 The necrotic cores of advanced human atheromata abound with cells which react with monoclonal antibodies that recognize mononuclear phagocytes. 2413 The SMC that bear class IIHLA markers are found in the vicinity of these infiltrating leukocytes in atheromata, but SMC in uninvolved arterial tissue seldom exhibit these antigens. 13 These various findings indicate activation of the immune system in the human atherosclerotic lesion.
Traditionally, only cells derived from bone marrow were thought capable of expressing class II MHC antigens. It is now clear that vascular endothelial cells, certain epithelial cells, cells in the central nervous system, and even human fibroblasts can express class II MHC molecules in an inducible manner. 7 -12 Immune IFN, also known as IFN-y, is thought to be the physiologic inducer of class II expression on classical antigen presenting cells such as the monocyte/macrophage. Since the human atheromata contains leukocytes capable of IFN-y secretion, this cytokine may be a pathophysiobgically relevant modulator of class II antigen expression in the vessel wall as well. Indeed, the supernatant from a human mixed leukocyte reaction, which contains the secretory products of activated mononuclear cells, induced surface expression of class II MHC antigens on SMC (Figure 1 ). This study used defined cultures of human vascular SMC and a panel of human cytokines to explore the regulation of MHC gene expression in these cells.
As expected, SMC expressed class I antigens constitutively, although all of the interferons tested (with the exception of IL-6, also known as ft-interferon) caused modest increases in class I MHC mRNA and surface antigen. Other experiments indicated that the cytokines IL-1 and TNF may actually supress class I surface expression in these cells (data not shown). In contrast, IFN-y markedly increased the expression of class II genes in SMC. In the absence of this cytokine, only rare cells in SMC cultured without added stimuli reacted with anticlass II MHC antibodies ( Figure 5A ). Exposure to IFN-y, even at low concentrations (10 U/ml), provoked substantial accumulation of class II MHC mRNA and induced the expression of class II MHC antigen on the surface of the treated cells. Immunohistochemical study showed that IFN-y caused uniform appearance of class II antigen, indicating that all SMC in these cultures responded as a homogeneous population to this cytokine ( Figure 5 ). These various data support a strong effect of IFN-y on the transcription of class II MHC genes and the synthesis and surface expression of class II gene products by human vascular SMC.
The ability of SMC to express class II MHC genes in an inducible manner has several important implications for the pathogenesis of vascular diseases. The surface class II MHC product is required for accessory function in antigen presentation. 561011^8 Only cells that bear these determinants can efficiently present antigen to helper T-cells or be recognized as foreign by these cells. Even when induced to express class II MHC antigens, SMC or Cultures of human saphenous vein SMC were exposed to IFN-a (1000 U/ml) (left panels) or IFN-y (1000 U/ml) (right panels) for the indicated time periods. Northem analysis of cellular mRNA was performed as described in the legend to Figure 2 and in Methods. The upper panels show the result of a hybridization with a class II MHC probe (HLA-DR a). The middle panels show the result of a different hybridization of the same Northern blot with a class I MHC probe (HLA-B7). The bottom panel presents a photograph under ultraviolet illumination of the filter used for this northem hybridization and demonstrates the integrity and adequacy of the transfer of RNA in all lanes.
fibroblasts appear less effective in stimulating an allogeneic immune response in vitro than are endothelial cells obtained from the same human donor. 28 Fibroblasts also appear less immunogenic than endothelial cells, although both cell types bear class II antigens. 29 Nonetheless,
evidence from murine models of vasculitis suggest the The present findings on MHC gene regulation in SMC, taken together with recent immunohistochemical studies from other laboratories, suggest possible mechanisms for ongoing immune activation in chronic human atherosclerosis. Our observation that human SMC appear to require IFN-y to express Class II MHC genes suggests that mononudear leukocytes found in the plaque are in an activated state that is associated with production of this cytokine. This conclusion implies, in turn, that human atheromata probably contain cytokines such as interieukins, since activated mononudear phagocytes release these substances and because the usual pathway for T-cell activation involves such co-stimulatory mediators. sions in young individuals studied at autopsy contain T-lymphocytes, many of which bear markers of the suppressor/cytotoxic rather than helper/inducer subclass. 13 Although there is little doubt that a primary immune mechanism characterizes certain forms of vasculitis, there is neither convincing evidence nor reason to suspect that immunological derangements initiate the usual form of human atherosclerosis. However, in one specialized form of arteriosclerosis, that which arises in the coronary arteries of cardiac allografts, a primary immune mechanism may, indeed, be pathogenic. Host leukocytes can recognize donor cells as foreign only if they express the class II MHC product. In addition, some cytolytic T-lymphocytes can recognize O 4 Days Figure 8 . Immune interferon produces time-dependent increases in the expression of class II major histocompatibility (MHC) antigen on the surface of human vascular smooth muscle cells (SMC). Cultures of human saphenous vein SMC were exposed to IFN-y (1000 U/ml) for the indicated time periods. Class II MHC expression was measured by the enzyme-linked immunosorbent assay technique with monoclonal antibody 12. Data shown are mean±SD, n=8. allogeneic class II MHC antigens as foreign. 39 Thus, the ability of SMC to express class II MHC genes may contribute to both the afferent and the effector limbs of the cellular immune response to SMC in the tunica media of transplanted coronary arteries. This accelerated arteriosclerosis in the coronaries of allografted hearts is currently a major limitation in clinical cardiac transplantation. Further studies of the mechanism of interactions between leukocyte products and human vascular cells will doubtless continue to provide new insights into the pathogenesis of this and other human vascular diseases and may eventually suggest new therapies. 
